[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL103939A - An anti-DBI vaccine in birds containing attenuated live DBI virus - Google Patents

An anti-DBI vaccine in birds containing attenuated live DBI virus

Info

Publication number
IL103939A
IL103939A IL10393992A IL10393992A IL103939A IL 103939 A IL103939 A IL 103939A IL 10393992 A IL10393992 A IL 10393992A IL 10393992 A IL10393992 A IL 10393992A IL 103939 A IL103939 A IL 103939A
Authority
IL
Israel
Prior art keywords
vaccine
virus
infectious bursal
bursal disease
poultry
Prior art date
Application number
IL10393992A
Other languages
English (en)
Hebrew (he)
Other versions
IL103939A0 (en
Original Assignee
Abic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL10393992A priority Critical patent/IL103939A/en
Application filed by Abic Ltd filed Critical Abic Ltd
Publication of IL103939A0 publication Critical patent/IL103939A0/xx
Priority to HU9303369A priority patent/HU214737B/hu
Priority to US08/159,424 priority patent/US5804195A/en
Priority to RU93053037A priority patent/RU2126268C1/ru
Priority to PL93301253A priority patent/PL177386B1/pl
Priority to KR1019930026190A priority patent/KR0127116B1/ko
Priority to ZA938952A priority patent/ZA938952B/xx
Priority to ES93309595T priority patent/ES2147557T3/es
Priority to AT93309595T priority patent/ATE191644T1/de
Priority to CN93121559A priority patent/CN1072962C/zh
Priority to DE69328341T priority patent/DE69328341T2/de
Priority to EP93309595A priority patent/EP0600723B1/en
Priority to CZ932605A priority patent/CZ282443B6/cs
Priority to BR9304911A priority patent/BR9304911A/pt
Publication of IL103939A publication Critical patent/IL103939A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10393992A 1992-12-01 1992-12-01 An anti-DBI vaccine in birds containing attenuated live DBI virus IL103939A (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IL10393992A IL103939A (en) 1992-12-01 1992-12-01 An anti-DBI vaccine in birds containing attenuated live DBI virus
HU9303369A HU214737B (hu) 1992-12-01 1993-11-29 Eljárás fertőző nyálkatömlő-gyulladás kezelésére szolgáló vakcina és hatóanyag-vírustörzsek előállítására
US08/159,424 US5804195A (en) 1992-12-01 1993-11-30 Vaccine comprising an infectious bursal disease virus MB, MB-1 or MB-2 strain
RU93053037A RU2126268C1 (ru) 1992-12-01 1993-11-30 Вакцина для профилактики инфекционного заболевания сумки у цыплят, лиофилизированная вирусная композиция, способ защиты цыплят от этого заболевания и способ получения живой вакцины
PL93301253A PL177386B1 (pl) 1992-12-01 1993-11-30 Kompozycja wirusowa do szczepionki do zapobiegania infekcyjnej chorobie torebek u drobiu,szczepionka do zapobiegania infekcyjnej chorobie torebek u drobiu oraz sposób otrzymywania szczepionki do zapobiegania infekcyjnej chorobie torebek u drobiu
KR1019930026190A KR0127116B1 (ko) 1992-12-01 1993-11-30 전염성 점액낭 질병의 예방을 위한 왁찐
ZA938952A ZA938952B (en) 1992-12-01 1993-11-30 Infectious bursal disease vaccine
ES93309595T ES2147557T3 (es) 1992-12-01 1993-12-01 Vacuna de la enfermedad bursal infecciosa.
BR9304911A BR9304911A (pt) 1992-12-01 1993-12-01 Vacina, composiçao virotica liofilizada, processo para proteçao de aves domésticas e processo para preparaçao de vacina viva.
AT93309595T ATE191644T1 (de) 1992-12-01 1993-12-01 Impfstoff gegen infektiöse bursal-krankheit
CN93121559A CN1072962C (zh) 1992-12-01 1993-12-01 传染性囊病疫苗
DE69328341T DE69328341T2 (de) 1992-12-01 1993-12-01 Impfstoff gegen infektiöse Bursal-Krankheit
EP93309595A EP0600723B1 (en) 1992-12-01 1993-12-01 Infectious bursal disease vaccine
CZ932605A CZ282443B6 (cs) 1992-12-01 1993-12-01 Očkovací látka pro prevenci infekční bursitidy u drůbeže a způsob její výroby

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10393992A IL103939A (en) 1992-12-01 1992-12-01 An anti-DBI vaccine in birds containing attenuated live DBI virus

Publications (2)

Publication Number Publication Date
IL103939A0 IL103939A0 (en) 1993-05-13
IL103939A true IL103939A (en) 1996-09-12

Family

ID=11064287

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10393992A IL103939A (en) 1992-12-01 1992-12-01 An anti-DBI vaccine in birds containing attenuated live DBI virus

Country Status (14)

Country Link
US (1) US5804195A (ko)
EP (1) EP0600723B1 (ko)
KR (1) KR0127116B1 (ko)
CN (1) CN1072962C (ko)
AT (1) ATE191644T1 (ko)
BR (1) BR9304911A (ko)
CZ (1) CZ282443B6 (ko)
DE (1) DE69328341T2 (ko)
ES (1) ES2147557T3 (ko)
HU (1) HU214737B (ko)
IL (1) IL103939A (ko)
PL (1) PL177386B1 (ko)
RU (1) RU2126268C1 (ko)
ZA (1) ZA938952B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0861665A1 (en) * 1997-02-03 1998-09-02 Dimminaco Ag/Sa/Ltd. Infectious bursitis vaccine
KR20000056034A (ko) * 1999-02-12 2000-09-15 에릭 발리베 스테이터코일의 와인딩장치
WO2005049077A2 (en) * 2003-11-17 2005-06-02 Regents Of The University Of Minnesota Avian vaccine effective against infectious bursal disease virus
NZ549687A (en) * 2004-03-12 2008-08-29 Wyeth Corp Infectious bursal disease virus antigenic isolates and vaccines
JP2008512443A (ja) 2004-09-09 2008-04-24 カイロン ベーリング ゲーエムベーハー アンド カンパニー インフルエンザワクチンに関連する潜在的医原性リスクの減少
CN103143007B (zh) * 2013-02-27 2014-10-01 哈药集团生物疫苗有限公司 一种利用传代鸡胚成纤维细胞制备传染性法氏囊病毒活疫苗的方法
KR101511712B1 (ko) * 2013-04-03 2015-04-13 주식회사 카브 신규 전염성 ｆ낭병 바이러스 ｉｂｄ ｋ7주 및 이를 이용한 전염성 ｆ낭병 백신
WO2016020730A1 (es) * 2014-08-08 2016-02-11 Laboratorio Avi-Mex, S.A. De C.V. Vacuna en vector recombinante de adenovirus aviar serotipo 9
CA2994970A1 (en) 2015-08-14 2017-02-23 Clearh2O, Inc. High throughput process for delivering semi-firm gel for poultry

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3584055A (en) * 1966-06-18 1971-06-08 Basf Ag Production of butyraldehydes and butanols with a high proportion of linear compounds
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US5064646A (en) * 1988-08-02 1991-11-12 The University Of Maryland Novel infectious bursal disease virus
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
NZ235474A (en) * 1989-10-18 1992-12-23 Univ Maryland Virus capable of inducing infectious bursal disease; assay and vaccine

Also Published As

Publication number Publication date
PL177386B1 (pl) 1999-11-30
DE69328341D1 (de) 2000-05-18
CZ260593A3 (en) 1994-06-15
ATE191644T1 (de) 2000-04-15
KR940013536A (ko) 1994-07-15
RU2126268C1 (ru) 1999-02-20
EP0600723A2 (en) 1994-06-08
IL103939A0 (en) 1993-05-13
DE69328341T2 (de) 2000-12-14
HUT67324A (en) 1995-03-28
EP0600723A3 (en) 1995-01-11
CN1072962C (zh) 2001-10-17
ZA938952B (en) 1994-08-02
HU214737B (hu) 2000-03-28
CN1113158A (zh) 1995-12-13
CZ282443B6 (cs) 1997-07-16
ES2147557T3 (es) 2000-09-16
BR9304911A (pt) 1994-06-14
US5804195A (en) 1998-09-08
EP0600723B1 (en) 2000-04-12
PL301253A1 (en) 1994-06-13
HU9303369D0 (en) 1994-03-28
KR0127116B1 (ko) 1998-04-01

Similar Documents

Publication Publication Date Title
JP3947254B2 (ja) 組合わせタイプのニューカッスル病ウイルスワクチン
CA1232543A (en) Infectious bursal disease vaccine
AU696656B2 (en) Chimeric infectious bursal disease virus cDNA clones, expression products and vaccines based thereon
US6086892A (en) Poultry vaccine
US7462479B2 (en) Infectious bronchitis virus vaccine
US4302444A (en) Vaccines for immunizing egg-laying birds against Egg Drop disease, preparation of said vaccines, and method of use of said vaccines
US5728569A (en) Chicken anaemia agent vaccine
US5804195A (en) Vaccine comprising an infectious bursal disease virus MB, MB-1 or MB-2 strain
KR100540856B1 (ko) 뉴우캐슬병에 대한 난내 백신접종
JP3945842B2 (ja) 弱毒性ニューカッスル病ウイルスワクチン
AU782013B2 (en) IBDV strain for in ovo administration
US5686287A (en) Marek's disease virus vaccine
US5037650A (en) Live combination vaccine
US5686077A (en) Methods of immunization of poultry with vaccines against chicken anemia agent (CAA)
KR100759769B1 (ko) 광범위한 감염성 활액낭 질병 바이러스 백신
KR810001063B1 (ko) 생 뉴캣슬(Newcastle)병 바이러스 백신의 제법
AU633349B2 (en) Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired